U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Primary hypothyroidism

MedGen UID:
1389835
Concept ID:
C4316995
Disease or Syndrome
Synonyms: Hypothyroidism, Primary; Primary Hypothyroidism; Primary Hypothyroidisms
SNOMED CT: Primary hypothyroidism (57185003)
 
HPO: HP:0000832

Definition

A type of hypothyroidism that results from a defect in the thyroid gland. [from HPO]

Term Hierarchy

Conditions with this feature

Megalocornea-intellectual disability syndrome
MedGen UID:
162904
Concept ID:
C0796086
Disease or Syndrome
A rare intellectual disability syndrome with most common characteristics of megalocornea, congenital hypotonia, varying degrees of intellectual disability, psychomotor/developmental delay, seizures, and mild facial dysmorphism (including round face, frontal bossing, antimongoloid slant of the eyes, epicanthal folds, large low set ears, broad nasal base, anteverted nostrils, and long upper lip). Interfamilial and intrafamilial clinical variability has been reported.
Hypohidrotic ectodermal dysplasia-hypothyroidism-ciliary dyskinesia syndrome
MedGen UID:
384046
Concept ID:
C1857052
Disease or Syndrome
A rare, genetic, ectodermal dysplasia syndrome characterized by the association of hypohidrotic ectodermal dysplasia (manifesting with the triad of hypohidrosis, anodontia/hypodontia and hypotrichosis) with primary hypothyroidism and respiratory tract ciliary dyskinesia. Patients frequently present urticaria pigmentosa-like skin pigmentation, increased mast cells and melanin depositions in the dermis and severe, recurrent chest infections. There have been no further descriptions in the literature since 1986.
Ectodermal dysplasia-intellectual disability-central nervous system malformation syndrome
MedGen UID:
347363
Concept ID:
C1857053
Disease or Syndrome
Ectodermal dysplasia-intellectual disability-central nervous system malformation syndrome is a rare, multiple developmental anomalies syndrome characterized by the triad of ectodermal dysplasia (mostly hypohidrotic with dry skin and reduced sweating and sparse, fair scalp hair, eyebrows and eyelashes), severe intellectual disability and variable central nervous system anomalies (cerebellar hypoplasia, dilatation of ventricles, corpus callosum agenesis, Dandy-Walker malformation). Distinct craniofacial dysmorphism with macrocephaly, frontal bossing, midfacial hypoplasia and high arched or cleft palate, as well as cryptorchidism, feeding difficulties and hypotonia, are associated. There have been no further descriptions in the literature since 1998.
Nephropathic cystinosis
MedGen UID:
419735
Concept ID:
C2931187
Disease or Syndrome
Cystinosis comprises three allelic phenotypes: Nephropathic cystinosis in untreated children is characterized by renal Fanconi syndrome, poor growth, hypophosphatemic/calcipenic rickets, impaired glomerular function resulting in complete glomerular failure, and accumulation of cystine in almost all cells, leading to cellular dysfunction with tissue and organ impairment. The typical untreated child has short stature, rickets, and photophobia. Failure to thrive is generally noticed after approximately age six months; signs of renal tubular Fanconi syndrome (polyuria, polydipsia, dehydration, and acidosis) appear as early as age six months; corneal crystals can be present before age one year and are always present after age 16 months. Prior to the use of renal transplantation and cystine-depleting therapy, the life span in nephropathic cystinosis was no longer than ten years. With these interventions, affected individuals can survive at least into the mid-forties or fifties with satisfactory quality of life. Intermediate cystinosis is characterized by all the typical manifestations of nephropathic cystinosis, but onset is at a later age. Renal glomerular failure occurs in all untreated affected individuals, usually between ages 15 and 25 years. The non-nephropathic (ocular) form of cystinosis is characterized clinically only by photophobia resulting from corneal cystine crystal accumulation.

Professional guidelines

PubMed

Leung AKC, Leung AAC
World J Pediatr 2019 Apr;15(2):124-134. Epub 2019 Feb 8 doi: 10.1007/s12519-019-00230-w. PMID: 30734891
van der Kaay DC, Wasserman JD, Palmert MR
Pediatrics 2016 Apr;137(4) Epub 2016 Mar 15 doi: 10.1542/peds.2015-1878. PMID: 26980880
Almandoz JP, Gharib H
Med Clin North Am 2012 Mar;96(2):203-21. Epub 2012 Feb 14 doi: 10.1016/j.mcna.2012.01.005. PMID: 22443971

Curated

UK NICE Guideline NG145, Thyroid disease: assessment and management, 2019

Recent clinical studies

Etiology

Hegedüs L, Bianco AC, Jonklaas J, Pearce SH, Weetman AP, Perros P
Nat Rev Endocrinol 2022 Apr;18(4):230-242. Epub 2022 Jan 18 doi: 10.1038/s41574-021-00625-8. PMID: 35042968Free PMC Article
Kostopoulou E, Miliordos K, Spiliotis B
Hormones (Athens) 2021 Jun;20(2):225-236. Epub 2021 Jan 5 doi: 10.1007/s42000-020-00267-x. PMID: 33400193
Ralli M, Angeletti D, Fiore M, D'Aguanno V, Lambiase A, Artico M, de Vincentiis M, Greco A
Autoimmun Rev 2020 Oct;19(10):102649. Epub 2020 Aug 15 doi: 10.1016/j.autrev.2020.102649. PMID: 32805423
Almandoz JP, Gharib H
Med Clin North Am 2012 Mar;96(2):203-21. Epub 2012 Feb 14 doi: 10.1016/j.mcna.2012.01.005. PMID: 22443971
Khandelwal D, Tandon N
Drugs 2012 Jan 1;72(1):17-33. doi: 10.2165/11598070-000000000-00000. PMID: 22191793

Diagnosis

Cherella CE, Wassner AJ
Curr Opin Endocrinol Diabetes Obes 2020 Feb;27(1):63-69. doi: 10.1097/MED.0000000000000520. PMID: 31789720
Chiovato L, Magri F, Carlé A
Adv Ther 2019 Sep;36(Suppl 2):47-58. Epub 2019 Sep 4 doi: 10.1007/s12325-019-01080-8. PMID: 31485975Free PMC Article
Vilar L, Vilar CF, Lyra R, Freitas MDC
Neuroendocrinology 2019;109(1):7-19. Epub 2019 Mar 20 doi: 10.1159/000499694. PMID: 30889571
Persani L
J Clin Endocrinol Metab 2012 Sep;97(9):3068-78. Epub 2012 Jul 31 doi: 10.1210/jc.2012-1616. PMID: 22851492
Almandoz JP, Gharib H
Med Clin North Am 2012 Mar;96(2):203-21. Epub 2012 Feb 14 doi: 10.1016/j.mcna.2012.01.005. PMID: 22443971

Therapy

Chaker L, Razvi S, Bensenor IM, Azizi F, Pearce EN, Peeters RP
Nat Rev Dis Primers 2022 May 19;8(1):30. doi: 10.1038/s41572-022-00357-7. PMID: 35589725
Cherella CE, Wassner AJ
Curr Opin Endocrinol Diabetes Obes 2020 Feb;27(1):63-69. doi: 10.1097/MED.0000000000000520. PMID: 31789720
Chiovato L, Magri F, Carlé A
Adv Ther 2019 Sep;36(Suppl 2):47-58. Epub 2019 Sep 4 doi: 10.1007/s12325-019-01080-8. PMID: 31485975Free PMC Article
Persani L
J Clin Endocrinol Metab 2012 Sep;97(9):3068-78. Epub 2012 Jul 31 doi: 10.1210/jc.2012-1616. PMID: 22851492
Khandelwal D, Tandon N
Drugs 2012 Jan 1;72(1):17-33. doi: 10.2165/11598070-000000000-00000. PMID: 22191793

Prognosis

Hannan MA, Kamrul-Hasan AB, Karim MN, Selim S, Stocker MR, Diug B, Ilic D, Mustari M, Haq T, Fariduddin M
Mymensingh Med J 2022 Apr;31(2):449-457. PMID: 35383766
Kristan MM, Toro-Tobon D, Francis N, Desale S, Bikas A, Jonklaas J, Goyal RM
Front Endocrinol (Lausanne) 2022;13:798253. Epub 2022 Mar 11 doi: 10.3389/fendo.2022.798253. PMID: 35360059Free PMC Article
Abbade RCF, Fernandes A, Zantut-Wittmann DE, Parisi MCR, Pavin EJ
Gynecol Endocrinol 2020 Feb;36(2):126-130. Epub 2019 Jun 22 doi: 10.1080/09513590.2019.1631282. PMID: 31232118
Leung AKC, Leung AAC
World J Pediatr 2019 Apr;15(2):124-134. Epub 2019 Feb 8 doi: 10.1007/s12519-019-00230-w. PMID: 30734891
Mantovani A, Nascimbeni F, Lonardo A, Zoppini G, Bonora E, Mantzoros CS, Targher G
Thyroid 2018 Oct;28(10):1270-1284. Epub 2018 Aug 30 doi: 10.1089/thy.2018.0257. PMID: 30084737

Clinical prediction guides

Liu X, Yuan J, Zhou H, Wang Y, Tian G, Liu X, Wang X, Tang M, Meng X, Kou C, Yang Q, Li J, Zhang L, Ji J, Zhang H
J Clin Endocrinol Metab 2023 Mar 10;108(4):941-949. doi: 10.1210/clinem/dgac614. PMID: 36263677
Beck-Peccoz P, Rodari G, Giavoli C, Lania A
Nat Rev Endocrinol 2017 Oct;13(10):588-598. Epub 2017 May 26 doi: 10.1038/nrendo.2017.47. PMID: 28549061
Kawicka A, Regulska-Ilow B, Regulska-Ilow B
Postepy Hig Med Dosw (Online) 2015 Jan 2;69:80-90. doi: 10.5604/17322693.1136383. PMID: 25614676
Persani L
J Clin Endocrinol Metab 2012 Sep;97(9):3068-78. Epub 2012 Jul 31 doi: 10.1210/jc.2012-1616. PMID: 22851492
Markou K, Georgopoulos N, Kyriazopoulou V, Vagenakis AG
Thyroid 2001 May;11(5):501-10. doi: 10.1089/105072501300176462. PMID: 11396709

Recent systematic reviews

van der Leij S, Lebbink CA, Lentjes EG, Tissing WJ, Stuart AV, van den Heuvel-Eibrink MM, van Santen HM, van Dalen EC
Crit Rev Oncol Hematol 2023 Apr;184:103958. Epub 2023 Mar 11 doi: 10.1016/j.critrevonc.2023.103958. PMID: 36907363
Lan H, Wen J, Mao Y, Huang H, Chen G, Lin W
Clin Endocrinol (Oxf) 2022 Jul;97(1):13-25. Epub 2022 Apr 27 doi: 10.1111/cen.14742. PMID: 35445422
Guzman-Prado Y, Vita R, Samson O
J Gen Intern Med 2021 Jun;36(6):1726-1733. Epub 2021 Jan 19 doi: 10.1007/s11606-020-06403-y. PMID: 33469743Free PMC Article
Mantovani A, Nascimbeni F, Lonardo A, Zoppini G, Bonora E, Mantzoros CS, Targher G
Thyroid 2018 Oct;28(10):1270-1284. Epub 2018 Aug 30 doi: 10.1089/thy.2018.0257. PMID: 30084737

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Curated

    • NICE, 2019
      UK NICE Guideline NG145, Thyroid disease: assessment and management, 2019

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...